Phase II trial of esorubicin in the treatment of metastatic carcinoma of the kidney: a study of the Northern California Oncology Group

Cancer Treat Rep. 1987 Jul-Aug;71(7-8):767-8.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Blood Cell Count
  • California
  • Carcinoma / drug therapy*
  • Carcinoma / mortality
  • Doxorubicin / adverse effects
  • Doxorubicin / analogs & derivatives*
  • Doxorubicin / therapeutic use
  • Drug Evaluation
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / mortality
  • Middle Aged
  • Neoplasm Metastasis

Substances

  • Doxorubicin
  • esorubicin